Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-03
2005-05-03
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S300000, C930S020000, C930S030000, C930S320000
Reexamination Certificate
active
06887845
ABSTRACT:
The present invention provides spreading agents based on sequence-specific oligomers comprising a peptoid, a peptide-peptoid chimera, a retropeptoid or a retro(peptoid-peptide) chimera, and methods for using the same, including for the treatment of respiratory distress of the lungs. The spreading agents are sequence-specific oligomers, including retrosequence-specific oligomers, based on a peptide backbone, that are designed as analogs of surfactant protein-B or surfactant protein-C.
REFERENCES:
Nillson et al. Synthetic peptide-containing surfactants (1998) Eur. J. Biochem. vol. 255, pp. 116-124.*
Ding, Takamoto, Nahmen, Lipp, Lee, Waring, and Zasadzinski, “Effects of Lung Surfactant Proteins, SP-B and SP-C, and Palmitic Acid on Monolayer Stability”, Biophysical Journal, May 2001, pp. 2262-2272, vol. 80, Biophysical Society, California.
Lipp, Lee, Zasadzinski, and Waring, “Phase and Morphology Changes in Lipid Monolayers Induced by SP-B Protein and its Amino-Terminal Peptide”, Science Magazine, Aug. 30, 1996, pp. 1196-1199, vol. 273.
Kirschenbaum, Barron, Goldsmith, Armand, Bradley, Truong, Dill, Cohen and Zuckermann, “Sequence-specific polypeptoids: A diverse family of heteropolymers with stable secondary structure”, Proc. Natl. Acad. Sci., USA, Apr. 1998, pp. 4303-4308, vol. 95. The National Academy of Sciences.
Barron Annelise E.
Wu Cindy W.
Zuckermann Ronald N.
Chiron Corporation
Northwestern University
Reinhart Boerner Van Deuren s.c.
Schnizer Holly
Weber Jon
LandOfFree
Polypeptoid pulmonary surfactants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptoid pulmonary surfactants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptoid pulmonary surfactants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3408460